No black box warning on record for Adakveo

As of the latest FDA labeling reviewed, Adakveo (CRIZANLIZUMAB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Adakveo medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Infusion-Related Reactions: Monitor for and advise patients of signs and symptoms. Discontinue ADAKVEO infusion for severe reactions and manage medically. Temporarily interrupt or slow the rate of infusion for mild or moderate infusion-related reactions and initiate symptomatic treatment. Exercise caution with corticosteroids in patients with sickle cell disease unless c

No black box warning on record for Adakveo

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Infusion-Related Reactions: Monitor for and advise patients of signs and symptoms. Discontinue ADAKVEO infusion for severe reactions and manage medically. Temporarily interrupt or slow the rate of infusion for mild or moderate infusion-related reactions and initiate symptomatic treatment. Exercise caution with corticosteroids in patients with sickle cell disease unless c

Adakveo Black Box Warning

No black box warning on record for Adakveo

Other warnings & precautions

Adakveo Black Box Warning

No black box warning on record for Adakveo

Other warnings & precautions